Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Gene Expression Oncology Reference Lab Testing for VISN19

U.S. Department Of Veterans Affairs·Colorado

Gene Expression Oncology Reference Lab Testing for VISN19

Closes 11/12/2025$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing Oncotype Genetic (Gene Expression) Reference Lab Testing Services. The services include specimen preparation and storage, transportation of clinical laboratory specimens, performance of analytical testing, reporting of analytical test results, and consultative services. The Contractor shall be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and all applicable federal and state laws. The required gene expression tests include Oncotype DX Breast Recurrence Score Assay, Oncotype DX Breast DCIS Score Assay, Oncotype DX Colon Recurrence Score Assay, Oncoguard Liver CPT, OncoExtra, and Cologuard CPT. • The services are required for the following VA Medical Centers: Rocky Mountain Regional VA Medical Center, VA Montana Health Care System, Oklahoma City VA Health Care System, and Salt Lake City VA Health Care System. • The Contractor shall be capable of providing the required gene expression tests or equivalent tests. • The NAICS code to be used for this acquisition is 621511. • Responses and questions may be submitted electronically to [email protected] and [email protected] in a Microsoft word compatible format.

Attached files

Contact

Juanita Street(Contracting Officer)

[email protected]

Key dates

Opened
11/5/2025
Closes
11/12/2025

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
621511
Solicitation №
36C259-25-AP-1137

Budget estimate

$100,000 – $500,000

The budget for this opportunity is difficult to estimate, as the document does not provide a specific budget or payment amount. However, based on the required services, which include gene expression testing and laboratory services, the budget may be in the range of $100,000 to $500,000 per year, depending on the number of tests and services provided. The budget may also be influenced by the number of VA Medical Centers requiring the services and the frequency of testing.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Department Of Veterans Affairs·New Jersey

Top match · 67%

Q301--Reference and Esoteric Laboratory Testing

Closes 11/30/2026Opened 10/30/2026

U.S. National Institutes of Health·United States of America

65% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

65% match

Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)

Closes 1/11/2027Opened 9/17/2025

U.S. National Institutes of Health·United States of America

65% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

65% match

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)

Closes 1/24/2028Opened 10/13/2026

U.S. National Institutes of Health·United States of America

64% match

Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/18/2026

U.S. National Institutes of Health·United States of America

64% match

Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Closes 6/10/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

64% match

RNomics Molecular Standards

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

64% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

64% match

HIV/AIDS Clinical Trials Network Laboratory Centers

Closes 1/21/2027Opened 4/8/2026

U.S. National Institutes of Health·United States of America

64% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

64% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

63% match

Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 3/24/2026

U.S. National Institutes of Health·United States of America

63% match

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/8/2023

Mental Health, NYS Office of·New York

63% match

IFB 26-067 FLU/PCR, CT/NG PCR and HCV/PCR Testing

Closes 12/3/2026Opened 10/16/2026

U.S. National Institutes of Health·United States of America

63% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

63% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

63% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

63% match

Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/6/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

LA County Health Services·California

63% match

Request Applications for Reference Medical Laboratory Services

Rolling / TBD closeOpened 10/3/2023